Myelodysplastic syndromes (MDS)are clinically characterized by morphological dysplasias of blood cells and cytopenias of variable combinations due to ineffective hematopoiesis (1). They often transform into acute myeloid leukemia (AML) as designated preleukemic syndromes. About 60% of cases with MDScarry a non-randomchromosome abnormality such as -7, 7q-, -5, 5q-, 20q-etc and/or complex abnormalities, proving that MDSis a clonal hemopathy which originates in a multipotent hematopoietic stem cell.
Immunological manifesta tion Patients with MDSusually manifest only a few symptoms related to anemia. However,a minor proportion of the patients suffers froma variety of symptoms suggestive of autoimmune disorders; pyoderma gangrenosum, Sweet's syndrome, Bechetlike recurrent aptha, polyarthritis, polychondritis, vasculitis, hypothyroidism, hemolytic anemia, pure red cell anemia, immunethrombocytopenia and rare cases of pernicious anemia (2^). All these manifestation are suggestive of someimmune pathology, although the underlying abnormality of the immune system has not been precisely elucidated. In this issue of Internal Medicine, Funato et al reported such a case of MDSwith hypoadrenalism and Addison's disease (5) .
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Furthermore this case had somecharacteristics of rheumatoid arthritis and positive Coombs' test. The pancytopenia and hypoadrenalism were successfully treated with prednisolone. Such a hypoadrenalism complicated with MDShas not been reported in the literature. Amongthe endocrine organ-related immuneabnormalities hypothyroidism is more frequent. Several reports indicated considerably high rates of association between MDSand immunological abnormalities of laboratory tests such as hyper-gammaglobulinemia, hypogammaglobulinemia, M-protein, positive Coombs' tests, positive RAtests, low CD4/8 ratio, etc. These immunological abnormalities usually respond well to conventional immunosuppressive therapy such as corticosteroid therapy. However, Okamotoet al suggested that MDSpatients with immunological abnormalities have a significantly shorter survival compared with those without (4).
Clonal blood diseases and immunological disorders Amonghematological malignancies such autoimmune disorders are most frequently seen in lymphoid malignancies such as malignant lymphomas and chronic lymphoid leukemia (CLL) and far less frequently associated with acute leukemia and chronic myeldid leukemia (CML). The high rate of association between lymphoid malignancies and autoimmune disor- 
Effects of immunosuppressive therapy
From the therapeutic point of view, it is interesting to note that Funato et al obtained a good response with corticostroid therapy for the immunedisorders as well as the pancytopenia. In spite of this relief from clinical symptomsand pancytopenia, morphological dysplasias still persisted. Although this case lacks firm evidence of clonal disorder due to the normal karyotypes of bone marrowcells, it is interesting to note that the pancytopenia responded very well to conventional immunosuppressive therapy. Such cases have been reported but sporadically.
More recently Molldrem et al reported a 60% response rate in MDScases with anti-thymocyte globulin (ATG) (8) . Others reported similar results with cyclosporin A (CSA) (9) . Although these response rates are slightly less than those reported for aplastic anemia (10) with ATGor CSA suggest that there may be immunological suppression of MDSclones which might otherwise be able to produce moremature cells. In somecases of aplastic anemia oligoclonal cytotoxic T-cells are reportedly involved in the pathogenesis of stem cell suppression or injury (1 1). It is also interesting that sometimes aplastic anemia which shows a good response to immunosuppressivetherapy later evolves into MDS with an apparent cytogenetic abnormality such as -7 anomaly (10). Thus, one can speculate that there is some immune-mediated pathology in both MDSand aplastic anemia. Interestingly, the autoimmune disorders reported in MDShave been far less observed in aplastic anemia. This mayreflect the difference in cellularity of bone marrow between the two diseases.
Perspectives of future study Theoretically, the cells of abnormal clones of MDSmay either carry some abnormal antigens derived from acquired genetic abnormalities related to cellular transformation in MDS or involve lymphocytes within MDSclones which may exert abnormal functions. Normal residual lymphocytes may react to the former aberrant MDS clones or abnormal lymphocyte clones themselves may render immune disorder (s) in MDS patients.
The detection of such abnormalities at cellular and molecular levels is warranted to elucidate the immune pathology of MDS.Such studies will also clarify the similarity or dissimilarity between MDSand AA.
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